• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期住院患者 1 年死亡率的预测因素。

Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease.

机构信息

Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.

出版信息

Respiration. 2013;85(1):15-26. doi: 10.1159/000342036. Epub 2012 Oct 2.

DOI:10.1159/000342036
PMID:23037178
Abstract

BACKGROUND

Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are related to high mortality, especially in hospitalized patients. Predictors for severe outcomes are still not sufficiently defined.

OBJECTIVES

To assess the mortality rate and identify potential determinants of mortality in a cohort of patients hospitalized for AE-COPD.

METHODS

A retrospective, observational cohort study including all consecutive patients admitted between January 1, 2009, and April 1, 2010, for AE-COPD. Potential predictors were assessed at initial presentation at the emergency room. The primary outcome was mortality during 1-year follow-up. Univariate and multivariate time-to-event analyses using Cox proportional hazard models were employed for statistical analysis.

RESULTS

A total of 260 patients were enrolled in this study. Mean age was 70.5 ± 10.8 years, 50.0% were male and 63.4% had severe COPD. The in-hospital mortality rate was 5.8% and the 1-year mortality rate was 27.7%. Independent risk factors for mortality were age [hazard ratio (HR) = 1.04; 95% confidence interval (CI) = 1.01-1.07], male sex (HR = 2.00; 95% CI = 1.15-3.48), prior hospitalization for AE-COPD in the last 2 years (HR = 2.56; 95% CI = 1.52-4.30), prior recorded congestive heart failure (HR = 1.75; 95% CI = 1.03-2.97), PaCO₂ ≥6.0 kPa (HR = 2.90; 95% CI = 1.65-5.09) and urea ≥8.0 mmol/l (HR = 2.38; 95% CI = 1.42-3.99) at admission.

CONCLUSIONS

Age, male sex, prior hospitalization for AE-COPD in the last 2 years, prior recorded congestive heart failure, hypercapnia and elevated levels of urea at hospital admission are independent predictors of mortality within the first year after admission.

摘要

背景

慢性阻塞性肺疾病(COPD)急性加重(AE-COPD)与高死亡率相关,尤其是在住院患者中。严重结局的预测因素仍未得到充分明确。

目的

评估住院 COPD 急性加重患者的死亡率,并确定死亡的潜在决定因素。

方法

这是一项回顾性、观察性队列研究,纳入了 2009 年 1 月 1 日至 2010 年 4 月 1 日期间因 AE-COPD 住院的所有连续患者。在急诊室初始就诊时评估潜在预测因素。主要结局为 1 年随访期间的死亡率。采用 Cox 比例风险模型进行单变量和多变量时间事件分析。

结果

这项研究共纳入了 260 名患者。平均年龄为 70.5 ± 10.8 岁,50.0%为男性,63.4%患有严重 COPD。住院期间的死亡率为 5.8%,1 年死亡率为 27.7%。死亡率的独立危险因素包括年龄[风险比(HR)=1.04;95%置信区间(CI)=1.01-1.07]、男性(HR=2.00;95%CI=1.15-3.48)、过去 2 年内因 AE-COPD 住院(HR=2.56;95%CI=1.52-4.30)、既往记录的充血性心力衰竭(HR=1.75;95%CI=1.03-2.97)、入院时 PaCO₂≥6.0 kPa(HR=2.90;95%CI=1.65-5.09)和尿素≥8.0 mmol/l(HR=2.38;95%CI=1.42-3.99)。

结论

年龄、男性、过去 2 年内因 AE-COPD 住院、既往记录的充血性心力衰竭、入院时高碳酸血症和尿素水平升高是入院后 1 年内死亡的独立预测因素。

相似文献

1
Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期住院患者 1 年死亡率的预测因素。
Respiration. 2013;85(1):15-26. doi: 10.1159/000342036. Epub 2012 Oct 2.
2
In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.首次因慢性阻塞性肺疾病急性加重住院患者的院内及一年死亡率及其预测因素:一项基于全国人口的研究。
PLoS One. 2014 Dec 9;9(12):e114866. doi: 10.1371/journal.pone.0114866. eCollection 2014.
3
Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.因慢性阻塞性肺疾病急性加重住院的老年患者长期生存的预测因素。
Respirology. 2008 Nov;13(6):851-5. doi: 10.1111/j.1440-1843.2008.01367.x.
4
Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.加拿大急诊科慢性阻塞性肺疾病加重期患者住院的预测因素
Acad Emerg Med. 2009 Apr;16(4):316-24. doi: 10.1111/j.1553-2712.2009.00366.x. Epub 2009 Mar 6.
5
Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.铜绿假单胞菌与慢性阻塞性肺疾病患者住院后的死亡率。
Respiration. 2012;84(1):36-43. doi: 10.1159/000331224. Epub 2011 Oct 12.
6
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.吸气量可预测慢性阻塞性肺疾病患者的死亡率。
Respir Med. 2008 Apr;102(4):613-9. doi: 10.1016/j.rmed.2007.11.004. Epub 2007 Dec 20.
7
Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.慢性阻塞性肺疾病急性加重期住院后的死亡相关因素:临床特征的负担
Am J Emerg Med. 2007 Jun;25(5):515-22. doi: 10.1016/j.ajem.2006.09.014.
8
Mortality after first hospitalization for chronic obstructive pulmonary disease: changes in 1980-1998.慢性阻塞性肺疾病首次住院后的死亡率:1980 - 1998年的变化
Cent Eur J Public Health. 2004 Mar;12(1):19-20.
9
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.长期护理机构中医疗保险受益人的慢性阻塞性肺疾病负担
Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.
10
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.与异丙托溴铵相比,使用丙酸氟替卡松500微克/沙美特罗50微克进行初始维持治疗的老年人慢性阻塞性肺疾病住院/急诊就诊风险及治疗费用。
Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005.

引用本文的文献

1
Sensing molecular carbon dioxide: a translational focus for respiratory disease.感知分子二氧化碳:呼吸系统疾病的转化研究重点
Physiol Rev. 2025 Oct 1;105(4):2657-2691. doi: 10.1152/physrev.00022.2024. Epub 2025 Jul 16.
2
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
3
Clinical factors associated with the use of NIV in the pre-hospital setting in adult patients treated for acute COPD exacerbation: a single-center retrospective cohort study.
成年急性慢性阻塞性肺疾病加重期患者院前使用无创通气的相关临床因素:一项单中心回顾性队列研究
BMC Emerg Med. 2025 Feb 27;25(1):32. doi: 10.1186/s12873-025-01193-0.
4
COVID-19 and risk of long-term mortality in COPD: a nationwide population-based cohort study.2019冠状病毒病与慢性阻塞性肺疾病的长期死亡风险:一项基于全国人群的队列研究
BMJ Open Respir Res. 2025 Feb 17;12(1):e002694. doi: 10.1136/bmjresp-2024-002694.
5
The clinical characteristics associated with the ratio between the main pulmonary artery and ascending aorta diameter in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者主肺动脉与升主动脉直径比值相关的临床特征
J Thorac Dis. 2024 Aug 31;16(8):4924-4934. doi: 10.21037/jtd-24-62. Epub 2024 Aug 28.
6
Elevated BUN Upon Admission as a Predictor of in-Hospital Mortality Among Patients with Acute Exacerbation of COPD: A Secondary Analysis of Multicenter Cohort Study.入院时 BUN 升高可预测 COPD 急性加重患者住院期间的死亡率:一项多中心队列研究的二次分析。
Int J Chron Obstruct Pulmon Dis. 2023 Jul 13;18:1445-1455. doi: 10.2147/COPD.S412106. eCollection 2023.
7
Acute COPD exacerbation treatment with noninvasive ventilation.无创通气治疗急性 COPD 加重。
Sci Rep. 2023 Apr 21;13(1):6586. doi: 10.1038/s41598-023-33871-z.
8
The Role of Early Warning Scoring Systems NEWS and MEWS in the Acute Exacerbation of COPD.早期预警评分系统NEWS和MEWS在慢性阻塞性肺疾病急性加重中的作用
Clin Med Insights Circ Respir Pulm Med. 2023 Jan 24;17:11795484231152305. doi: 10.1177/11795484231152305. eCollection 2023.
9
Chronic moderate hypercapnia suppresses ventilatory responses to acute CO<sub>2</sub> challenges.慢性中度高碳酸血症抑制急性 CO₂ 挑战的通气反应。
J Appl Physiol (1985). 2022 Nov 1;133(5):1106-1118. doi: 10.1152/japplphysiol.00407.2022. Epub 2022 Sep 22.
10
Development and validation of a prognostic nomogram among patients with acute exacerbation of chronic obstructive pulmonary disease in intensive care unit.开发和验证重症监护病房慢性阻塞性肺疾病急性加重患者的预后列线图。
BMC Pulm Med. 2022 Aug 9;22(1):306. doi: 10.1186/s12890-022-02100-0.